Published in Clin Pharmacol Ther on May 01, 1997
Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients. Eur J Clin Pharmacol (2005) 1.06
Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability. J Int AIDS Soc (2013) 1.05
CYP3A4 and the erythromycin breath test. Clin Pharmacol Ther (1998) 0.90
Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers. Antimicrob Agents Chemother (2000) 0.85
Gefitinib-phenytoin interaction is not correlated with the C-erythromycin breath test in healthy male volunteers. Br J Clin Pharmacol (2009) 0.85
Pharmacokinetics of ritonavir and delavirdine in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (2003) 0.84
Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells. PLoS One (2015) 0.78
Antiretroviral therapy for patients with HIV disease. Br J Clin Pharmacol (1998) 0.75
Effect of fluconazole on the steady-state pharmacokinetics of delavirdine in human immunodeficiency virus-positive patients. Antimicrob Agents Chemother (1997) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
THE EFFECT OF COMBINATION WITH DIAZO COMPOUNDS ON THE IMMUNOLOGICAL REACTIVITY OF ANTIBODIES. J Exp Med (1936) 7.43
Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature (2001) 5.95
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet (2001) 5.80
Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med (1987) 5.74
Effect of Gibberellin on Germination of Lettuce Seed. Science (1957) 5.27
Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med (1993) 4.72
Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circ Res (1995) 4.55
Weight gain continues in the 1990s: 10-year trends in weight and overweight from the CARDIA study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol (2000) 4.49
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis (2001) 4.01
Group C streptococcal bacteremia: analysis of 88 cases. Rev Infect Dis (1991) 3.88
Relaxation of a single DNA molecule observed by optical microscopy. Science (1994) 3.58
Stretching of a single tethered polymer in a uniform flow. Science (1995) 3.48
Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med (1994) 3.32
Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med (1991) 3.03
Single polymer dynamics in an elongational flow. Science (1997) 2.92
Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest (1997) 2.89
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78
NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Am J Med (1994) 2.60
Direct observation of tube-like motion of a single polymer chain. Science (1994) 2.60
A new nomenclature for IL-1-family genes. Trends Immunol (2001) 2.57
Use of a colorimetric system for yeast susceptibility testing. J Clin Microbiol (1995) 2.54
Cysteine Protection against X Irradiation. Science (1949) 2.52
Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther (2011) 2.50
Hydrogen mapping of the lunar south pole using the LRO neutron detector experiment LEND. Science (2010) 2.38
Characterization of monoclonal antibody to DNA.RNA and its application to immunodetection of hybrids. J Immunol Methods (1986) 2.31
The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics (2001) 2.29
The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res (1997) 2.28
The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis (2001) 2.25
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther (1997) 2.17
The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance. Clin Cancer Res (2000) 2.14
Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm (2000) 2.14
Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction (1997) 2.12
Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest (1992) 2.11
Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst (1999) 2.11
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis (2007) 2.09
Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clin Infect Dis (1996) 2.09
Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res (1998) 2.08
Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America. Clin Infect Dis (2000) 2.08
Crystalloid vs. colloid resuscitation: is one better? A randomized clinical study. Surgery (1979) 2.06
Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res (1996) 2.05
Alopecia associated with fluconazole therapy. Ann Intern Med (1995) 2.05
Seven-year trends in body weight and associations with lifestyle and behavioral characteristics in black and white young adults: the CARDIA study. Am J Public Health (1997) 2.01
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med (1992) 2.01
Expression pattern of Motch, a mouse homolog of Drosophila Notch, suggests an important role in early postimplantation mouse development. Development (1992) 1.99
Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages. Infect Immun (1981) 1.97
An ethics core curriculum for Australasian medical Schools. Med J Aust (2001) 1.95
Hepatic dysfunction associated with troglitazone. N Engl J Med (1998) 1.90
Staphylococcus aureus nasal colonization in a nursing home: eradication with mupirocin. Infect Control Hosp Epidemiol (1990) 1.90
Single-concentration broth microdilution test for detection of high-level aminoglycoside resistance in enterococci. J Clin Microbiol (1987) 1.85
Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates. Antimicrob Agents Chemother (1996) 1.83
Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 1.80
Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA Technical Panel on Infections Within Hospitals. Infect Control Hosp Epidemiol (1994) 1.79
Dawn at Vesta: testing the protoplanetary paradigm. Science (2012) 1.76
Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science (1990) 1.75
Internal structure and early thermal evolution of Mars from Mars Global Surveyor topography and gravity. Science (2000) 1.71
First-pass metabolism of cyclosporin by the gut. Lancet (1991) 1.71
Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol (1988) 1.69
5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm Res (1998) 1.66
CYP3A gene expression in human gut epithelium. Pharmacogenetics (1994) 1.66
Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J Biol Chem (2000) 1.62
Identification of an inducible form of cytochrome P-450 in human liver. Proc Natl Acad Sci U S A (1985) 1.62
Ancient geodynamics and global-scale hydrology on Mars. Science (2001) 1.61
Gentamicin resistance plasmids of enterococci from diverse geographic areas are heterogeneous. J Infect Dis (1988) 1.60
Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. Am J Physiol (1999) 1.59
Drosophila nuclear lamin precursor Dm0 is translated from either of two developmentally regulated mRNA species apparently encoded by a single gene. J Cell Biol (1988) 1.59
Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function. J Lab Clin Med (1978) 1.57
Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc Natl Acad Sci U S A (1986) 1.57
Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p. Biochemistry (1985) 1.57
Serum proteomic profiling in patients with drug-induced liver injury. Aliment Pharmacol Ther (2012) 1.55
Histoplasmosis in immunosuppressed patients. Am J Med (1978) 1.54
The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses (1990) 1.53
A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial. Ann Rheum Dis (2014) 1.52
Immunological identification of two sulfhydryl-containing fragments of human plasma fibronectin. J Biol Chem (1982) 1.52
Lymphogranuloma venereum. I. Comparison of the Frei test, complement fixation test, and isolation of the agent. J Infect Dis (1969) 1.52
Purulent pneumococcal pericarditis. A continuing problem in the antibiotic era. Am J Med (1973) 1.51
Adjuvant arthritis as a model of inflammatory cachexia. Arthritis Rheum (1997) 1.51
Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers. Infect Immun (1974) 1.50
High-level aminoglycoside-resistant enterococci. Colonization of nursing home and acute care hospital patients. Arch Intern Med (1987) 1.49
The management of flail chest. A comparison of ventilatory and nonventilatory treatment. Am J Surg (1976) 1.48
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. Clin Infect Dis (2001) 1.48
Blood gene expression signatures predict exposure levels. Proc Natl Acad Sci U S A (2007) 1.48
Torulopsis glabrata renal infection. Am J Med (1974) 1.48
Empirical and theoretical challenges in aboveground-belowground ecology. Oecologia (2009) 1.47
The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure. Int J Radiat Oncol Biol Phys (1990) 1.47
Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test. Drug Metab Dispos (1995) 1.46
Increasing resistance of Staphylococcus aureus to ciprofloxacin. Antimicrob Agents Chemother (1990) 1.45
Risk factors for colonization with yeast species in a Veterans Affairs long-term care facility. J Am Geriatr Soc (1998) 1.45
Severe acetaminophen toxicity in a patient receiving isoniazid. Ann Intern Med (1990) 1.45
Nitrate-enhanced thallium 201 single-photon emission computed tomography imaging in hibernating myocardium. Am Heart J (1999) 1.45
Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J Pharm Sci (2000) 1.45
Intermittent urethral catheterization in the elderly. J Am Geriatr Soc (1989) 1.43
Detection and characterization of mupirocin resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1993) 1.43
Benzodiazepine dependence and withdrawal: identification and medical management. J Am Board Fam Pract (1992) 1.43
Single- and multiple-dose-response relationships of beta-carotene in cystic fibrosis. J Pediatr (1995) 1.43
Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos (1997) 1.43
Group B streptococcal prosthetic joint infection following sigmoidoscopy. Clin Infect Dis (1992) 1.42
Bone marrow toxicity associated with 5-fluorocytosine therapy. Antimicrob Agents Chemother (1977) 1.42
Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol. J Pharm Sci (2004) 1.41